C oronary spasm plays an important role in the pathogenesis of ischemic heart disease.1,2 However, the mechanisms of coronary spasm have not been well understood. We have created a swine model of coronary spasm in which angiographically documentable coronary spasm associated with ST segment elevation could be provoked by histamine or serotonin 3 months after endothelial denudation with high cholesterol feeding with or without selective irradiation.3-5 Using this animal model of coronary spasm, we have demonstrated that coronary spasm occurred at the site of intimal thickening after denudation in the in vivo condition as well as in the excised heart,3-7 suggesting that coronary spasm was related to local atheroscle-rotic process but not to neurohormonal mechanisms. We also showed that coronary spasm could be prevented by selective blockers of H1-or S2-receptors of vascular smooth muscle7-9 and that smooth muscle reactivity to histamine or serotonin of excised coronary artery from the spastic segment was markedly augmented compared with that of the artery from the nonspastic segment.8, 10 These results suggest that serotonin-or histamine-induced coronary spasm in this swine model results from augmented contraction of vascular smooth muscle induced by altered receptormediated mechanisms.
However, the in vitro experiments also revealed that endothelium-dependent vasorelaxation evoked with serotonin and histamine was attenuated in excised coronary artery from the spastic segment compared with that in the artery from the nonspastic segment. 10 Such findings suggest the possibility that in addition to vascular smooth muscle hyperreactivity to agonists, defective endothelium-dependent vasorelaxation may contribute to coronary spasm. It has been implicated that defective endothelium-dependent vasodilation may play an important role in coronary spasm in patients with variant angina, since acetylcholine provokes coronary spasm in those patients. 1" This study aimed to determine the role of vascular smooth muscle hyperreactivity and defective endothelial function to serotonin-induced coronary spasm in the swine model. The relative roles of those two mechanisms in coronary spasm must be assessed in the in vivo condition, since coronary spasm is defined angiographically as a local hyperconstriction of the coronary artery producing myocardial ischemia.12, 12 We examined the decreases in the coronary artery diameter evoked with serotonin before and after N@-nitro-L-arginine methyl ester (LNNA), which inhibits nitric oxide biosynthesis13-15 at the denuded site and irradiated segment (the spastic site) and at the nondenuded segment (the nonspastic site). We also examined the increases in the coronary artery diameter evoked with substance P, an endothelium-dependent vasodilator, before and after LNNA at the two sites.
Methods

Animal Preparation
Thirteen male Gottingen miniature pigs (Nihon Crea Inc, Tokyo) (4 to 6 months old, 15 to 21 kg in weight) were housed individually under controlled room temperature and were fed minipig chow containing 2% cholesterol (Nihon Crea Inc, Tokyo). The denudation of the left coronary artery was undertaken as follows. Pigs were sedated with intramuscular ketamine hydrochloride (12.5 mg/kg) and were then anesthetized with an intravenous administration of sodium pentobarbital (20 mg/kg). Animals were then intubated and ventilated via a positive-pressure respirator (Shinano Inc, Tokyo). Arterial pH, Po2 and Pco2 were kept within normal ranges. Using sterile surgery, an 8F green Kifa catheter (Kifa, Stockholm) was inserted from the carotid artery into the orifice of the left coronary artery. After an intravenous injection of 3000 units of heparin, the midportion of the left anterior descending coronary artery was denuded using a balloon catheter as described.3 Coronary arteriograms were recorded before and after the denudation procedure to determine the denuded site, which revealed mild constriction immediately after denudation. Pigs were then brought back to the houses and kept for 3 months. To produce advanced atherosclerotic lesions, x-ray was irradiated selectively to the denuded area twice at 4 and 6 weeks after the endothelial denudation as described.4,5 X-ray was collimated to the area of 5 cm in diameter, and the total dose of irradiation was Protocol 3. This protocol was done in the 6 pigs that were used in the study of protocol 2. A week after the study of protocol 2, serotonin at the graded doses was administered into the left coronary artery before and after 3 mg/kg of LNNA as described in protocol 1. After the pretreatment with PGF2a (10 pug/kg), the effects of substance P at the graded doses of 1, 3, and 10 pg/kg were also studied before and after LNNA at the high dose (3 mg/kg), as described in protocol 1. Since LNNA at the high dose increased arterial pressure by more than 25 mm Hg, the a-blocker phentolamine (1 mg/kg by bolus followed by infusion of 1 mg/min) was simultaneously infused intravenously during the study with 3 mg/kg of LNNA in order to prevent the systemic pressor effect of 3 mg/kg of LNNA.
Each dose of the drug was diluted with 1 mL of physiological saline, and the same amount of saline was used to flush the catheter. During the study, the catheter position was fixed, and an equal amount of drug solution was injected into the left coronary artery.
Histological Study
Pigs were killed with a lethal dose of sodium pentobarbital and exsanguination, and then the heart was excised. The left coronary artery was perfused with 2% buffered glutaraldehyde solution at the pressure of 90 mm Hg. The spastic and nonspastic segments of the left coronary artery were resected and fixed with glutaraldehyde solution for a few days. Tissue samples used for light microscopic examination were embedded in paraffin, sectioned at 5-1£m thickness, mounted on glass slides, and stained with hematoxylin-eosin, using van Gieson methods. Samples used for scanning electron microscopic examination were dried, longitudinally bisected, mounted on alminum studs, coated with gold, and examined using (Fig 4) .
Scanning electron microscopy disclosed an intact lining of endothelial cells of a fusiform shape at the control site. The abnormal appearances of the regenerated multishaped endothelial cells of varying sizes were noted at the denuded site (Fig 4) .
Discussion
The major findings of this study are fourfold. First, an intracoronary administration of serotonin provoked coronary spasm associated with ischemic ST segment elevation at the denuded site 3 months after endothelial denudation and x-ray irradiation. Second, endotheliumdependent vasodilation was markedly attenuated at the denuded site as compared with that at the control site. ated) vasodilation (Tables 1 and 2 and Fig 2) . However, in contrast to the findings at the control site, LNNA did not alter serotonin-induced vasoconstriction at the denuded site. Second, we examined coronary vasodilation evoked with substance P after pretreatment with PGF2, before and after LNNA. PGF2, caused mild and comparable vasoconstriction at the denuded and control sites before and after LNNA (Tables 1 and 2 ). It is shown that substance P induces endothelium-dependent vasodilation and has no direct effect on vascular smooth muscle.18-21 Before LNNA, substance P caused significantly greater vasodilation at the control site than at the denuded site (Fig 3) . Furthermore, LNNA significantly attenuated substance P-induced vasodilation at the control site but did not alter it at the denuded site. Thus, coronary vasodilation mediated by nitric oxide evoked with two agonists, serotonin and substance P, was more markedly attenuated at the denuded site than at the control site. It appears that vascular smooth muscle response to nitric oxide did not differ between the denuded and control sites, since SIN-i-induced vasodilation was comparable between the two sites (Table 4 ). These findings suggest that endotheliumdependent vasodilation via nitric oxide in response to serotonin and substance P was defective at the previously denuded and spastic sites.
We confirmed histologically that the endothelium was regenerated 3 months after denudation, although the reported that even in the swine without cholesterol diet, the endothelium-dependent relaxations to serotonin and aggregating platelets were impaired from 4 to 24 weeks after endothelium removal in the previously denuded arteries with regenerated endothelium.
It is interesting to note that substance P caused coronary vasodilation after LNNA at the denuded and control site (Table 3 and Fig 3) . Since the increase in the dose of LNNA did not further attenuate substance P-induced coronary vasodilation (Table 3) , it was unlikely that inhibition of nitric oxide synthesis by LNNA was inadequate. We consider the possibility that substance P-induced coronary vasodilation after LNNA was mediated by endothelium-dependent mechanisms other than release of nitric oxide, since substance P has no direct vasorelaxing effect on vascular smooth muscle.18-21 It has been suggested that substance P may evoke vasorelaxation by facilitating release of endothelium-dependent hyperpolarizing factor in pig coronary artery. 24 Our findings indicate that substance P-induced coronary vasodilation after LNNA was comparable between the denuded and control sites (Fig 3) , suggest- ing the possibility that the release of endothelium-LNNA by ANOVA of repeated measures dependent hyperpolarizing factor by substance P may not be attenuated at the denuded site, although synthesis of nitric oxide is defective. However, this possibility needs to be examined in future studies.
Mechanisms of Coronary Spasm in the Swine Model
The major aim of this study was to determine the relative roles of endothelial dysfunction and vascular smooth muscle hyperreactivity in serotonin-induced coronary spasm in the swine model. Vascular smooth muscle reactivity to serotonin was assessed by examining coronary vasoconstriction evoked with serotonin after LNNA. Serotonin-induced coronary vasoconstriction after LNNA was significantly greater (P<.01) at the denuded site than at the control site (Fig 2) , indicating that vascular smooth muscle at the denuded site was hyperreactive to serotonin 3 months after denudation. The results shown in Fig 2 suggest that the contribution of defective nitric oxide production to serotonin-induced hypercontraction at the denuded site may be a function of the serotonin dose. More important, after LNNA, serotonin at the highest dose (10 jig/kg) caused the coronary diameter reduction of only 31+±1% at the control site and did not cause myocardial ischemia, whereas serotonin-induced vasoconstriction at the denuded site was approximately 80% before and after LNNA and was associated with myocardial ischemia (Fig  2) . These findings strongly suggest that inhibition of nitric oxide synthesis was not enough to cause coronary vasospasm and that serotonin-induced coronary vasospasm in this swine model resulted primarily from hypercontraction of vascular smooth muscle to serotonin. We cannot exclude the possibility that other endothelium-related mechanisms such as endothelium-depen- 
Conclusions
The results demonstrated that endothelium-dependent vasodilation mediated by nitric oxide was attenuated at the denuded and irradiated segments of coronary artery where coronary spasm was induced by serotonin. However, attenuated endothelium-dependent vasodilation via nitric oxide was unlikely to account for coronary spasm, since serotonin-induced vasoconstriction after LNNA at the control site was markedly less than that at the denuded and spastic sites. It is reasonable to consider that serotonin-induced coronary spasm in this swine model resulted primarily from hyperreactivity of vascular smooth muscle to serotonin at the denuded site. We do not exclude the possibility, however, that several endothelium-derived factors different from nitric oxide may be involved in the pathogenesis of coronary spasm.
